Free Trial

Sotera Health (SHC) Competitors

Sotera Health logo
$15.27 -0.22 (-1.42%)
Closing price 04:00 PM Eastern
Extended Trading
$15.27 0.00 (0.00%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SHC vs. GH, FMS, BTSG, CELC, and HIMS

Should you buy Sotera Health stock or one of its competitors? MarketBeat compares Sotera Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sotera Health include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Sotera Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Sotera Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M12.82-$416.28M-$3.39N/A
Sotera Health$1.19B3.66$77.94M$0.4137.24

Guardant Health currently has a consensus price target of $129.42, suggesting a potential upside of 36.35%. Sotera Health has a consensus price target of $20.33, suggesting a potential upside of 33.16%. Given Guardant Health's stronger consensus rating and higher probable upside, research analysts plainly believe Guardant Health is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
1 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.86
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Guardant Health had 13 more articles in the media than Sotera Health. MarketBeat recorded 17 mentions for Guardant Health and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.26 beat Guardant Health's score of 0.61 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health has a net margin of 9.91% compared to Guardant Health's net margin of -40.10%. Sotera Health's return on equity of 39.73% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-40.10% N/A -26.42%
Sotera Health 9.91%39.73%7.05%

Guardant Health has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market.

Summary

Sotera Health beats Guardant Health on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $28.00, suggesting a potential upside of 29.54%. Sotera Health has a consensus target price of $20.33, suggesting a potential upside of 33.16%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Sotera Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.54$1.11B$1.9011.38
Sotera Health$1.19B3.66$77.94M$0.4137.24

Sotera Health has a net margin of 9.91% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.88%. Sotera Health's return on equity of 39.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Sotera Health 9.91%39.73%7.05%

In the previous week, Sotera Health had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for Sotera Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Sotera Health's average media sentiment score of 1.26 beat Fresenius Medical Care AG & Co. KGaA's score of 1.23 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Sotera Health beats Fresenius Medical Care AG & Co. KGaA on 13 of the 16 factors compared between the two stocks.

How does Sotera Health compare to BrightSpring Health Services?

Sotera Health (NASDAQ:SHC) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Sotera Health has a beta of 1.82, suggesting that its share price is 82% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to BrightSpring Health Services' net margin of 2.27%. Sotera Health's return on equity of 39.73% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
BrightSpring Health Services 2.27%14.63%4.41%

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, BrightSpring Health Services had 3 more articles in the media than Sotera Health. MarketBeat recorded 7 mentions for BrightSpring Health Services and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.26 beat BrightSpring Health Services' score of 0.67 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.19B3.66$77.94M$0.4137.24
BrightSpring Health Services$12.91B0.87$190.67M$1.4141.06

Sotera Health currently has a consensus price target of $20.33, indicating a potential upside of 33.16%. BrightSpring Health Services has a consensus price target of $56.29, indicating a potential downside of 2.79%. Given Sotera Health's higher possible upside, research analysts plainly believe Sotera Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

Summary

Sotera Health beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Sotera Health has a net margin of 9.91% compared to Celcuity's net margin of 0.00%. Sotera Health's return on equity of 39.73% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -203.17% -52.68%
Sotera Health 9.91%39.73%7.05%

Celcuity currently has a consensus price target of $140.20, suggesting a potential upside of 1.83%. Sotera Health has a consensus price target of $20.33, suggesting a potential upside of 33.16%. Given Sotera Health's higher probable upside, analysts clearly believe Sotera Health is more favorable than Celcuity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

Sotera Health has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$177.04M-$3.79N/A
Sotera Health$1.19B3.66$77.94M$0.4137.24

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Celcuity has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market.

In the previous week, Celcuity had 8 more articles in the media than Sotera Health. MarketBeat recorded 12 mentions for Celcuity and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.26 beat Celcuity's score of 0.65 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Positive
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Sotera Health beats Celcuity on 12 of the 15 factors compared between the two stocks.

How does Sotera Health compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.37B2.41$128.37M-$0.09N/A
Sotera Health$1.19B3.66$77.94M$0.4137.24

In the previous week, Hims & Hers Health had 71 more articles in the media than Sotera Health. MarketBeat recorded 75 mentions for Hims & Hers Health and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.26 beat Hims & Hers Health's score of -0.01 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
16 Very Positive mention(s)
10 Positive mention(s)
11 Neutral mention(s)
24 Negative mention(s)
6 Very Negative mention(s)
Neutral
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.82, indicating that its stock price is 82% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to Hims & Hers Health's net margin of -0.56%. Sotera Health's return on equity of 39.73% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Sotera Health 9.91%39.73%7.05%

Hims & Hers Health presently has a consensus target price of $29.50, indicating a potential upside of 17.70%. Sotera Health has a consensus target price of $20.33, indicating a potential upside of 33.16%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

Summary

Sotera Health beats Hims & Hers Health on 12 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricSotera HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$4.35B$8.17B$6.22B$12.27B
Dividend YieldN/A3.03%2.80%5.35%
P/E Ratio37.2420.7820.3825.28
Price / Sales3.6616.48542.5473.29
Price / Cash12.1181.2943.2656.33
Price / Book7.005.459.816.91
Net Income$77.94M$183.43M$3.56B$333.88M
7 Day Performance-3.23%-1.11%0.43%0.16%
1 Month Performance-4.74%8.70%-0.87%1.90%
1 Year Performance19.86%2.01%36.28%32.84%

Sotera Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Sotera Health
3.9625 of 5 stars
$15.27
-1.4%
$20.33
+33.2%
+20.9%$4.35B$1.19B37.243,000
GH
Guardant Health
3.3237 of 5 stars
$88.18
-3.3%
$128.63
+45.9%
+142.3%$11.70B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.8693 of 5 stars
$20.19
-10.9%
$28.00
+38.7%
-22.8%$11.29B$19.63B10.581,488
BTSG
BrightSpring Health Services
3.2887 of 5 stars
$52.46
-2.0%
$55.29
+5.4%
+148.6%$10.14B$12.91B37.2323,500
CELC
Celcuity
1.7527 of 5 stars
$140.36
-3.2%
$134.50
-4.2%
+1,140.5%$6.79BN/AN/A40

Related Companies and Tools


This page (NASDAQ:SHC) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners